ImmunityBio Inc. (IBRX)
2.96
-0.05 (-1.66%)
At close: Apr 01, 2025, 3:59 PM
2.99
0.98%
After-hours: Apr 01, 2025, 07:58 PM EDT
ImmunityBio Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -413.64M | -583.2M | -417.32M | -349.85M | -224.19M | -160.16M | -96.23M | -96.42M | -120.81M | -236.88M | -6.21M | -2.05M |
| Depreciation & Amortization | 22.59M | 18.51M | 18.26M | 14.24M | 12.74M | 14.04M | 9.55M | 5.57M | 3.61M | 1.47M | 128K | 4K |
| Stock-Based Compensation | 34.43M | 49.16M | 40.18M | 57.18M | 2.19M | 3.42M | 2.04M | 37M | 73.85M | 211.22M | n/a | n/a |
| Other Working Capital | n/a | 10.45M | -16M | -15.39M | 13.79M | -16.82M | 546K | 3.08M | 2.95M | -420K | 61.24M | 329K |
| Other Non-Cash Items | -34.61M | 144.79M | 29.38M | 23.13M | 24.11M | 6.23M | 44.55M | 50.33M | 81.67M | 212.36M | -61.05M | -365K |
| Deferred Income Tax | n/a | n/a | -4K | -8K | -2.94M | -8K | -498K | -497K | -575K | -302K | n/a | n/a |
| Change in Working Capital | n/a | 3.98M | -8M | -19.11M | 16.36M | -15.64M | -554K | 3.23M | 3.84M | 282K | 60.99M | 856K |
| Operating Cash Flow | -391.24M | -366.76M | -337.51M | -274.42M | -171.72M | -152.11M | -63.38M | -48.78M | -38.59M | -25.3M | -5.35M | -668K |
| Capital Expenditures | -6.89M | -30.58M | -99.39M | -33.56M | -1.67M | -4.29M | -13.1M | -34.81M | -6.56M | -2.24M | -299K | -3K |
| Acquisitions | -1M | n/a | -1M | 20.5M | 8K | 200K | 412K | -32K | -137K | -1.82M | n/a | n/a |
| Purchase of Investments | -140.22M | -10.36M | -34.31M | -141.75M | -91.77M | -87.19M | -95.49M | -119.86M | -273M | -198.07M | n/a | n/a |
| Sales Maturities Of Investments | 136.61M | 10.47M | 162M | 69.93M | 73.62M | 112.33M | 165.28M | 254.22M | 165.89M | 26.9M | n/a | n/a |
| Other Investing Acitivies | -747K | n/a | 105.46M | -51.32M | -8K | -2.5M | 35.03M | 32K | 137K | -1.82M | n/a | n/a |
| Investing Cash Flow | -12.25M | -30.47M | 27.3M | -84.89M | -19.81M | 18.55M | 57.1M | 99.55M | -113.67M | -175.22M | -299K | -3K |
| Debt Repayment | -64K | 258.62M | 174.07M | 338.5M | 63.7M | 47.67M | -477K | -19.93M | -32K | -132K | -53K | -1K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -2.5M | -228K | -15.23M | -15.85M | -4.8M | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 170.34M | 189.62M | -881K | 2.41M | 673K | 39.11M | -123K | -1.04M | -1.11M | -2.42M | 1.00 | n/a |
| Financial Cash Flow | 281.63M | 558.34M | 233.61M | 505.44M | 150.68M | 114.28M | -771K | -34.98M | -15.56M | 317.33M | 64.41M | 905K |
| Net Cash Flow | -121.88M | 160.82M | -76.31M | 146.19M | -40.89M | -19.3M | -7.05M | 15.79M | -167.82M | 116.8M | 58.75M | 234K |
| Free Cash Flow | -398.12M | -397.34M | -436.9M | -307.98M | -173.39M | -156.4M | -76.48M | -83.59M | -45.15M | -27.55M | -5.65M | -671K |